Ahmedabad (Gujarat) [India], April 10 (ANI): Zydus Lifesciences on Monday said it has received the final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Azithromycin Tablets USP, 500 mg.

Azithromycin is prescribed to treat certain bacterial infections such as bronchitis, pneumonia, sexually transmitted diseases (STD), and infections of the ears, lungs, sinuses, skin, throat, and reproductive organs.

Also Read | DC vs MI, Dream11 Team Prediction IPL 2023: Tips to Pick Best Fantasy Playing XI for Delhi Capitals vs Mumbai Indians, Indian Premier League Season 16 Match 16.

The drug will be manufactured at the group's formulation manufacturing facility in Moraiya, Ahmedabad, it informed stock exchanges.

Azithromycin Tablets USP, 500 mg has about annual sales of USD 20 million in the US. (ANI)

Also Read | Smriti Mandhana Takes Admission for BCom at Sanjay Ghodawat University in Kolhapur.

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)